Skip to main content

SERPINB4 Antibody (001) [Biotin]

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-90154B

Recombinant Monoclonal Antibody
Novus Biologicals, part of Bio-Techne

Key Product Details

Species Reactivity

Human

Applications

Immunohistochemistry-Paraffin

Label

Biotin

Antibody Source

Recombinant Monoclonal Rabbit IgG Clone # 001

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

This antibody was obtained from a rabbit immunized with purified, recombinant Human SERPINB4 (Uniprot#: P48594; Met1-Pro390).

Clonality

Monoclonal

Host

Rabbit

Isotype

IgG

Applications for SERPINB4 Antibody (001) [Biotin]

Application
Recommended Usage

Immunohistochemistry-Paraffin

Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Protein A purified

Formulation

PBS

Preservative

0.05% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C in the dark.

Background: Serpin B4

SERPINB4 may act as a protease inhibitor to modulate the host immune response against tumor cells

Long Name

Serpin Family B Member 4

Alternate Names

LEUPIN, Peptidase Inhibitor 11, PI11, SCCA2, SerpinB4

Gene Symbol

SERPINB4

Additional Serpin B4 Products

Product Documents for SERPINB4 Antibody (001) [Biotin]

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for SERPINB4 Antibody (001) [Biotin]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...